Literature DB >> 15176159

Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy.

Sandra Marchese Johnson1, Thomas D Horn.   

Abstract

Warts are a common dermatologic problem. There are many treatments available. Intralesional injection of a skin test antigen has been shown to be efficacious at eradicating all warts when only a part of one wart is injected. The aim of this study was to determine whether injection of the combination of Candida albicans, mumps, and Trichophyton skin test antigens was more efficacious than and as safe as single antigen injection. Seventy-one percent of subjects had resolution of their warts with the injection of the combination of skin test antigens in this open label single arm study.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15176159

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN： 1545-9616            Impact factor:   2.114


  14 in total

Review 1.  An armamentarium of wart treatments.

Authors:  Michelle M Lipke
Journal:  Clin Med Res       Date:  2006-12

Review 2.  Cross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic Vaccines.

Authors:  Mayumi Nakagawa; William Greenfield; Andrea Moerman-Herzog; Hannah N Coleman
Journal:  Clin Vaccine Immunol       Date:  2015-05-06

3.  Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination.

Authors:  Hannah N Coleman; William W Greenfield; Shawna L Stratton; Rita Vaughn; Alexander Kieber; Andrea M Moerman-Herzog; Horace J Spencer; Wilbur C Hitt; Charles Matthew Quick; Laura F Hutchins; Samuel G Mackintosh; Ricky D Edmondson; Stephen W Erickson; Mayumi Nakagawa
Journal:  Cancer Immunol Immunother       Date:  2016-03-15       Impact factor: 6.968

4.  Therapeutic Outcome of Intralesional Immunotherapy in Cutaneous Warts Using the Mumps, Measles, and Rubella Vaccine: A Randomized, Placebo-controlled Trial.

Authors:  Guneet Awal; Simplepreet Kaur
Journal:  J Clin Aesthet Dermatol       Date:  2018-05-01

5.  Intralesional Immunotherapy with Measles Mumps Rubella Vaccine for the Treatment of Anogenital Warts: An Open-label Study.

Authors:  Shilpi Sharma; Saurabh Agarwal
Journal:  J Clin Aesthet Dermatol       Date:  2020-08-01

6.  IL-12 secretion by Langerhans cells stimulated with Candida skin test reagent is mediated by dectin-1 in some healthy individuals.

Authors:  Mayumi Nakagawa; Hannah N Coleman; Xuelian Wang; Jaclyn Daniels; James Sikes; Uma M Nagarajan
Journal:  Cytokine       Date:  2013-12-02       Impact factor: 3.861

7.  Candida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine.

Authors:  Xuelian Wang; Hannah N Coleman; Uma Nagarajan; Horace J Spencer; Mayumi Nakagawa
Journal:  Vaccine       Date:  2013-10-14       Impact factor: 3.641

8.  Intralesional immunotherapy for difficult to treat warts with Mycobacterium w vaccine.

Authors:  Shilpa Garg; Sukriti Baveja
Journal:  J Cutan Aesthet Surg       Date:  2014 Oct-Dec

Review 9.  Evolving role of immunotherapy in the treatment of refractory warts.

Authors:  Devinder M Thappa; Minu J Chiramel
Journal:  Indian Dermatol Online J       Date:  2016 Sep-Oct

10.  Immunotherapy with intralesional Candida albicans antigen in resistant or recurrent warts: a study.

Authors:  Imran Majid; Saher Imran
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.